BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11319357)

  • 1. [Descriptive epidemiology and knowledge of erysipelas risk factors].
    Dupuy A
    Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 2):312-6. PubMed ID: 11319357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for erysipelas of the leg in Tunisia: a multicenter case-control study.
    Mokni M; Dupuy A; Denguezli M; Dhaoui R; Bouassida S; Amri M; Fenniche S; Zeglaoui F; Doss N; Nouira R; Ben Osman-Dhahri A; Zili J; Mokhtar I; Kamoun MR; Zahaf A; Chosidow O
    Dermatology; 2006; 212(2):108-12. PubMed ID: 16484815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk factors associated with leg erysipelas (cellulitis) in sub-Saharan Africa: A multicentre case-control study].
    Pitché P; Diatta B; Faye O; Diané BF; Sangaré A; Niamba P; Mandengue C; Kobengue L; Saka B; Diop A; Ly F; Dieng MT; Dicko A; Soumah MM; Cissé M; Kourouma SH; Kouassi YI; Boukari T; Akakpo S; Tchangaï-Walla K
    Ann Dermatol Venereol; 2015 Nov; 142(11):633-8. PubMed ID: 26364000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for erysipelas of the leg (cellulitis): case-control study.
    Dupuy A; Benchikhi H; Roujeau JC; Bernard P; Vaillant L; Chosidow O; Sassolas B; Guillaume JC; Grob JJ; Bastuji-Garin S
    BMJ; 1999 Jun; 318(7198):1591-4. PubMed ID: 10364117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow-up.
    Cox NH
    Br J Dermatol; 2006 Nov; 155(5):947-50. PubMed ID: 17034523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erysipelas in the young population of a military hospital].
    Mahé E; Toussaint P; Lamarque D; Boutchnei S; Guiguen Y
    Ann Dermatol Venereol; 1999; 126(8-9):593-9. PubMed ID: 10530346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erysipelas. Retrospective study of 647 patients].
    Zaraa I; Zeglaoui F; Zouari B; Ezzine N; Fazaa B; Kamoun MR
    Tunis Med; 2004 Nov; 82(11):990-5. PubMed ID: 15822466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent erysipelas: 47 cases.
    Leclerc S; Teixeira A; Mahé E; Descamps V; Crickx B; Chosidow O
    Dermatology; 2007; 214(1):52-7. PubMed ID: 17191048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and comorbidity of erysipelas in primary care.
    Bartholomeeusen S; Vandenbroucke J; Truyers C; Buntinx F
    Dermatology; 2007; 215(2):118-22. PubMed ID: 17684373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erysipelas--course of disease, recurrence, complications; a 10 years retrospective study].
    Wojas-Pelc A; Alekseenko A; Jaworek AK
    Przegl Epidemiol; 2007; 61(3):457-64. PubMed ID: 18069381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What data is needed today to deal with erysipelas?].
    Hansmann Y
    Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 2):419-28. PubMed ID: 11319374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological data and comorbidities of 428 patients hospitalized with erysipelas.
    Pereira de Godoy JM; Galacini Massari P; Yoshino Rosinha M; Marinelli Brandão R; Foroni Casas AL
    Angiology; 2010 Jul; 61(5):492-4. PubMed ID: 20147345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of common bacterial infections of the skin.
    Bernard P
    Curr Opin Infect Dis; 2008 Apr; 21(2):122-8. PubMed ID: 18317033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for acute cellulitis of the lower limb: a prospective case-control study.
    Björnsdóttir S; Gottfredsson M; Thórisdóttir AS; Gunnarsson GB; Ríkardsdóttir H; Kristjánsson M; Hilmarsdóttir I
    Clin Infect Dis; 2005 Nov; 41(10):1416-22. PubMed ID: 16231251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands.
    Goettsch WG; Bouwes Bavinck JN; Herings RM
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):834-9. PubMed ID: 16898907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Erysipelas of the leg in hospital environment in Lome (Togo)].
    Pitche P; Tchangaï-Walla K
    Bull Soc Pathol Exot; 1997; 90(3):189-91. PubMed ID: 9410258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Demographic, clinical and laboratory characteristics of erisypelas in the period 2001-2010].
    Vâţă D; Solovăstru LG; Vâţă A; Dorobăţ C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1042-7. PubMed ID: 22276443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study.
    Vignes S; Dupuy A
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):818-22. PubMed ID: 16898904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute bacterial skin infections and cellulitis.
    Gabillot-Carré M; Roujeau JC
    Curr Opin Infect Dis; 2007 Apr; 20(2):118-23. PubMed ID: 17496568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Erysipelas and impetigo].
    Cribier B
    Rev Prat; 1996 Sep; 46(13):1593-8. PubMed ID: 8949488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.